Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$336K Buy
928
+6
+0.7% +$2.05K 0.07% 100
2026
Q1
$324K Sell
922
-11
-1% -$3.92K 0.08% 104
2025
Q4
$305K Buy
933
+1
+0.1% +$317 0.07% 111
2025
Q3
$263K Sell
932
-11
-1% -$3.19K 0.06% 117
2025
Q2
$264K Buy
943
+12
+1% +$3.4K 0.07% 113
2025
Q1
$290K Buy
931
+46
+5% +$13.6K 0.1% 104
2024
Q4
$231K Buy
885
+65
+8% +$19.3K 0.07% 116
2024
Q3
$264K Sell
820
-6
-0.7% -$1.96K 0.08% 109
2024
Q2
$258K Sell
826
-22
-3% -$6.46K 0.08% 108
2024
Q1
$241K Buy
848
+46
+6% +$13.5K 0.07% 110
2023
Q4
$231K Sell
802
-33
-4% -$8.99K 0.08% 109
2023
Q3
$225K Buy
+835
New +$208K 0.08% 111
2022
Q2
Sell
-765
Closed -$185K 72
2022
Q1
$185K Buy
+765
New +$176K 0.12% 72
2018
Q2
Sell
-426
Closed -$71K 109
2018
Q1
$71K Buy
426
+3
+0.7% +$551 0.05% 114
2017
Q4
$74K Buy
+423
New +$74.9K 0.06% 106

Other funds holding AMGN

SWS Partners's AMGN Position: Q2 2026 in Review

SWS Partners increased its Amgen (AMGN) stake by 0.65% in Q2 2026, buying an estimated $2.05K and bringing the position to 928 shares worth $336K. The position accounts for 0.07% of the portfolio, ranked #100.

SWS Partners first reported a position in AMGN in Q4 2017 and has held it in 15 quarters since. 1,625 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • SWS Partners held 928 shares of Amgen worth $336K as of Q2 2026.
  • SWS Partners bought 6 Amgen shares in Q2 2026, an estimated $2.05K.
  • Amgen made up 0.07% of SWS Partners's portfolio in Q2 2026, its #100 holding.
  • SWS Partners first reported a position in Amgen in Q4 2017 and has held it in 15 quarters since.
  • 1,625 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on SWS Partners's 13F filing for Q2 2026, filed 3 Aug 2026.